| Literature DB >> 35010545 |
Brian Witrick1, Corey A Kalbaugh1,2, Lu Shi1, Rachel Mayo1, Brian Hendricks3.
Abstract
Readmissions constitute a major health care burden among peripheral artery disease (PAD) patients. This study aimed to 1) estimate the zip code tabulation area (ZCTA)-level prevalence of readmission among PAD patients and characterize the effect of covariates on readmissions; and (2) identify hotspots of PAD based on estimated prevalence of readmission. Thirty-day readmissions among PAD patients were identified from the South Carolina Revenue and Fiscal Affairs Office All Payers Database (2010-2018). Bayesian spatial hierarchical modeling was conducted to identify areas of high risk, while controlling for confounders. We mapped the estimated readmission rates and identified hotspots using local Getis Ord (G*) statistics. Of the 232,731 individuals admitted to a hospital or outpatient surgery facility with PAD diagnosis, 30,366 (13.1%) experienced an unplanned readmission to a hospital within 30 days. Fitted readmission rates ranged from 35.3 per 1000 patients to 370.7 per 1000 patients and the risk of having a readmission was significantly associated with the percentage of patients who are 65 and older (0.992, 95%CI: 0.985-0.999), have Medicare insurance (1.013, 1.005-1.020), and have hypertension (1.014, 1.005-1.023). Geographic analysis found significant variation in readmission rates across the state and identified priority areas for targeted interventions to reduce readmissions.Entities:
Keywords: disparities; peripheral artery disease; readmission; spatial analysis
Mesh:
Year: 2021 PMID: 35010545 PMCID: PMC8751080 DOI: 10.3390/ijerph19010285
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Patient-level characteristics of all-cause hospital 30-day readmission.
| All Patients | No 30-Day Readmission | Any 30-Day Readmission | ||
|---|---|---|---|---|
| Age, mean (SD) | 65.74 (14.23) | 65.56 (14.36) | 66.93 (13.31) | <0.001 |
| Gender (%) | <0.001 | |||
| Male | 127,150 (54.63) | 109,813 (54.26) | 17,337 (57.09) | |
| Female | 105,581 (45.37) | 92,552 (45.74) | 13,029 (42.91) | |
| Race/Ethnicity (%) | <0.001 | |||
| Non-Hispanic White | 159,372 (68.48) | 140,743 (69.55) | 18,629 (61.35) | |
| Non-Hispanic Black | 67,104 (28.83) | 55,872 (27.61) | 11,232 (36.99) | |
| Hispanic | 1421 (0.61) | 1291 (0.64) | 130 (0.43) | |
| Other | 4834 (2.08) | 4459 (2.20) | 375 (1.23) | |
| Insurance (%) | <0.001 | |||
| Private | 47,610 (20.46) | 43,788 (21.64) | 3822 (12.59) | |
| Medicare | 148,003 (63.59) | 125,672 (62.10) | 22,334 (73.54) | |
| Medicaid | 14,474 (6.22) | 121,187 (6.02) | 2287 (7.53) | |
| No Insurance | 12,351 (5.31) | 11,324 (5.60) | 1027 (3.38) | |
| Other | 10,292 (4.42) | 9393 (4.64) | 899 (2.96) | |
| Rurality (RUCA categorization C) | <0.001 | |||
| Rural | 70,626 (30.35) | 60,512 (29.90) | 10,114 (33.31) | |
| Urban | 162,105 (69.65) | 141,853 (70.10) | 20,252 (66.69) | |
| Diabetes | 129,417 (55.61) | 107,406 (53.08) | 22,011 (72.49) | <0.001 |
| COPD | 69,022 (29.66) | 54,681 (27.02) | 14,341 (47.23) | <0.001 |
| Hyperlipidemia | 144,850 (62.24) | 121,397 (59.99) | 23,453 (77.23) | <0.001 |
| Renal Failure | 23,361 (10.04) | 17,191 (8.50) | 6170 (20.32) | <0.001 |
| Chronic Kidney Disease | 110,195 (47.35) | 89,234 (44.10) | 20,961 (69.03) | <0.001 |
| CHF | 70,572 (30.32) | 53,687 (26.53) | 16,885 (55.60) | <0.001 |
| CAD | 119,615 (51.40) | 99,401 (49.12) | 20,214 (66.57) | <0.001 |
| Hypertension | 191,242 (82.17) | 162,263 (80.18) | 28,979 (95.43) | <0.001 |
COPD = chronic obstructive pulmonary disease; CHF = chronic heart failure; CAD = coronary artery disease.
Figure 1ZCTA level choropleth maps displaying crude and fitted readmission prevalence (a) Crude prevalence of PAD readmissions (b) Fitted prevalence of PAD readmissions.
Figure 2Choropleth maps of percent of comorbid conditions at the ZCTA level.
ZCTA Level prevalence rate ratios for covariates.
| ZCTA Variables | Prevalence Rate Ratio (95% CI) |
|---|---|
| Rural | 1.032 (0.980–1.086) |
| Percent CAD | 0.997 (0.993–1.002) |
| Percent Chronic Kidney Disease | 1.004 (0.998–1.011) |
| Percent Diabetes | 1.001 (0.993–1.008) |
| Percent Medicare | 1.013 (1.005–1.020) * |
| Percent Medicaid | 1.008 (0.998–1.019) |
| Percent Hyperlipidemia | 1.001 (0.995–1.007) |
| Percent 65 and older | 0.992 (0.985–0.999) * |
| Percent Black | 1.001 (1.000–1.004) |
| Percent CHF | 1.004 (0.997–1.012) |
| Percent COPD | 1.003 (0.997–1.012) |
| Percent Female | 1.003 (0.997–1.010) |
| Percent Renal Failure | 1.001 (0.994–1.014) |
| Percent Hypertension | 1.014 (1.005–1.023) * |
COPD = chronic obstructive pulmonary disease; CHF = chronic heart failure; CAD = coronary artery disease * Indicates substantially influential credible intervals for model covariates.
Figure 3Hot spot of estimated readmission prevalence.